Viewing Study NCT04470050


Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2026-05-15 @ 7:28 AM
Study NCT ID: NCT04470050
Status: COMPLETED
Last Update Posted: 2023-10-26
First Post: 2020-07-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
Sponsor: BioXcel Therapeutics Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Opioid Withdrawal View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Opioid View
None Opioid Addiction View
None Opioid Dependance View
None Opioid Withdrawal Symptoms View
None Opioid Withdrawal Syndrome View
None Morphine Addiction View
None delta-opioid receptors View
None Inhibition of nociceptive afferent neurons (PNS System) View
None Reduction of nociceptive transmission View
None Activation of descending inhibitory pathways (CNS System) View
None Analgesic Opioids View
None Drug craving View
None μ-δ-opioid (Mu-Delta) receptor View
None μ-binding (Mu receptors) View
None afferents within laminae I and II View
None κ-opioid receptor (KOR) View
None δ-opioid receptor (DOR) agonist View
None (+)-pentazocine View
None σ receptor antagonists View
None Downstream involvement of the σ receptor View
None Increase phosphorylation in p38 MAPK View
None IL-10 View
None Activation of IL-12 View
None IL-12 increase in T-cell immune response View
None pentacyclic 3°amine (alkaloid) View
None stereogenic centers View
None tetrahydroisoquinoline reticuline View
None CPY2D6 View
None benzylisoquinoline alkaloid View
None p38 MAPK-dependent pathway View
None kappa-opioid receptors View
None Short Opiate Withdrawal Scale (SOWS)-Gossop View
None Clinical Opiate Withdrawal Scale (COWS) View
None Agitation and Calmness Evaluation Scale (ACES) View
None Discontinuation of Morphine Maintenance View